Tokutaro Ogata
Overview
Explore the profile of Tokutaro Ogata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morimoto R, Matsubara C, Hanada A, Omoe Y, Ogata T, Isegawa Y
Pharmaceuticals (Basel)
. 2022 Dec;
15(12).
PMID: 36558931
Vaccines and antiviral drugs are widely used to treat influenza infection. However, they cannot rapidly respond to drug-resistant viruses. Therefore, new anti-influenza virus strategies are required. Naringenin is a flavonoid...
2.
Morimoto R, Hanada A, Matsubara C, Horio Y, Sumitani H, Ogata T, et al.
J Nat Med
. 2022 Dec;
77(1):228-229.
PMID: 36513844
No abstract available.
3.
Morimoto R, Hanada A, Matsubara C, Horio Y, Sumitani H, Ogata T, et al.
J Nat Med
. 2022 Nov;
77(1):219-227.
PMID: 36357821
Secondary plant metabolites from food extracts, namely daidzein, quercetin, and luteolin, exhibit anti-influenza virus effects, with IC values of 143.6, 274.8, and 8.0 μM, respectively. The activities of these metabolites...
4.
Hanada A, Morimoto R, Horio Y, Shichiri M, Nakashima A, Ogawa T, et al.
Food Sci Nutr
. 2022 Mar;
10(3):926-935.
PMID: 35282012
We previously demonstrated the anti-influenza activity of var. (wild watermelon, WWM); however, the active ingredient was unknown. Here, we performed metabolomic analysis to evaluate the ingredients of WWM associated with...
5.
Murota H, Shinya T, Nishiuchi A, Sakanaka M, Toda K, Ogata T, et al.
Drug Dev Res
. 2019 Jan;
80(3):395-402.
PMID: 30632632
Hit, Lead & Candidate Discovery Antiangiogenesis therapy is a promising way for treatment of solid cancers, and many angiogenesis inhibitors that target vascular endothelial growth factor (VEGF) or its receptors...
6.
Ogata T, Yoshida T, Tanaka M, Fukuhara C, Shimizu M, Ishii J, et al.
Chem Pharm Bull (Tokyo)
. 2015 Jul;
63(7):485-8.
PMID: 26133064
A new type of O-alkylation of 2-hydroxy-1,4-naphthoquinone with alkoxymethyl chlorides is described. The reaction course can be controlled by the choice of base and yields O-alkylated or O-alkoxymethylated products in...
7.
Nishiyama S, Ohba H, Kobashi T, Nakamasu Y, Nakao H, Ogata T, et al.
Synapse
. 2014 Apr;
68(7):283-92.
PMID: 24687885
Carbon-11-labeled (R,R)trans-8-methyl-2-hydroxy-3-[4-[2-aminophenyl]piperizinyl]-tetralin ([(11)C](R,R)HAPT) and its stereoisomer [(11)C](S,S)HAPT were developed for imaging vesicular acetylcholine transporters (VAChTs), exclusively located in presynaptic cholinergic neurons. Both positron emission tomography (PET) probes were evaluated in...
8.
Ogata T, Hartwig J
J Am Chem Soc
. 2008 Sep;
130(42):13848-9.
PMID: 18811161
Mild palladium-catalyzed aminations of aryl tosylates and the first aminations of heteroaryl tosylates are described. In the presence of the combination of L2Pd(0) (L = P(o-tol)3) and the hindered Josiphos...
9.
Tsuchida S, Kaneshige A, Ogata T, Baba H, Yamamoto Y, Tomioka K
Org Lett
. 2008 Jul;
10(16):3635-8.
PMID: 18642833
Consecutive cyclization of allylaminoalkenes by tandem aminolithiation-carbolithiation proceeded smoothly by using a lithium amide as a lithiating agent as well as protonating agent to give bicyclic amines, octahydroindolizine and hexahydro-1...
10.
Shen Q, Ogata T, Hartwig J
J Am Chem Soc
. 2008 May;
130(20):6586-96.
PMID: 18444639
We describe a systematic study of the scope and relationship between ligand structure and activity for a highly efficient and selective class of catalysts containing sterically hindered chelating alkylphosphines for...